Scipio bioscience develops a new generation of sample preparation solution for single-cell studies, in the form of user-friendly and cost-effective benchtop kits, for use in sequencing applications in clinical and basic research, with an initial focus on transcriptomics. Scipio Bioscience has developed the protocol from the initial proof-of-concept studies to a prototype kit ready for beta-testing in collaboration with several research teams. The company, founded in 2017, is hosted in the iPEPS-ICM incubator of the Brain & Spine Institute (ICM, Pitié-Salpêtrière Hospital, Paris).
Location: France, Ile-de-France
Employees: 11-50
Total raised: $8.68M
Founded date: 2017
Investors 2
| Date | Name | Website |
| 08.11.2022 | M Ventures | m-ventures... |
| - | Verve Vent... | verve.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.02.2020 | Series A | $7.27M | - |
| 14.11.2017 | Seed | $1.41M | - |
Mentions in press and media 5
| Date | Title | Description |
| 25.02.2020 | Scipio bioscience Secures €6.0M Series A Financing | Scipio bioscience, a Paris, France-based biotechnology company developing a new generation of single-cell sequencing solutions, secured a €6.0 M Series A financing. The round was led by M Ventures (Amsterdam, The Netherlands), the corporate... |
| 14.11.2017 | Scipio bioscience announces its seed funding of €1.2m obtained from Seventure Partners’ Quadrivium I seed fund and High-Tech Gründerfonds | Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces... |
| 14.11.2017 | Scipio bioscience Raises €1.2m in Seed Funding | Scipio bioscience, a Paris, France-based biotechnology company, raised €1.2m in seed funding. Backers included Seventure Partners’ Quadrivium I seed fund and High-Tech Gründerfonds. Led by Prof Stuart Edelstein, President, and Pierre Walraf... |
| - | Scipio bioscience raises €6.0 M Series A financing | Paris, 25 February 2020 - Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6.0 M Series A financing from an international syndica... |
| - | Scipio bioscience raises €6.0 M Series A financing to develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing | Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amst... |